chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a 17 month old male pt with no know medication allergies who on 09/19/2001 was vaccinated with the first dose of varicella vaccine SC in the right arm. There were no concomitant medications or illness at the time of vaccination. On 09/19/2001, the pt experienced "ataxia, kept falling down." The nurse reported that the pt's mother stated the child started "walking, staggering like he was drunk." the pt worsened through 09/23/2001 and would sometimes "fall flat." On 09/24/2001, the child developed a runny nose, cough and irritability. The child presented to the doctor's office on 09/25/2001 and was diagnosed with otitis media. The pt was treated with Amoxil. On 09/26/2001, the pt recovered. Additional info has been requested.
I had random episodes of my heart racing beginning the evening of the second dose of the Pfizer Vaccine.  It felt like my heart was taking off without me, something I've never had before.  They occurred randomly throughout the week after the shot with the last couple happening on Friday, March 19.  I did not go to the hospital as they would stop and not happen for another five or six hours.  I am concerned about taking a booster dose and have advised my physician of my concerns.
3/5/20 yesterday developed fever 100.4 Hurting at inj site then developed redness around inj site. That has been increasing in size, fever persist & vomiting started with no pain. Area monitored. Cephalexin for 10 days, wash with soap & water. Call if persists.
Full body hives, predominantly on the left side of the body (arms, legs, torso, head)
Pt reports that the night that she was vaccinated, she developed a full body rash with blistering.  Also experienced "nightmare anxiety."  Reported vomiting.
c/o feeling warm on left side going down the throat. Same feeling with first dose, this time not as severe as the first time. Denies chest pain, SOB, fatigue, lightheaded, rash, throat pain. No acute distress BP: 157/92 HR: 90 Sp02: 98% room air Seen and cleared by EMS
Ameliorated Varicella rash (Sib with same despite 2 VARIVAX immunizations).
03/04/21- 11:30pm chills, 03//05/21 AM-  pain and swelling  at injection site and whole left arm  lasting 2 days, fever late in the day of 03/05/21 gone morning of 03/06/21. with this came the urgency to urinate.  Had no side effects with first vaccine give 02/04/21.
L swollen arm with redness around site of shot. Itching complain it feel hot, some general increase temp 98 deg F.
Pt. vaccinated on 7 Apr. Approx 3 days later he develop a few bumps.  Over the past several days he has multiple lesions over his elbows, hands, fingers, knees, and palms.  C/o sore throat with odor.  Rash per pcm almost looks like EM or a Strep A rash.  No other symptoms, pt. otherwise well.
Body ache; Sore arm; A lot of tiredness; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body ache), PAIN IN EXTREMITY (Sore arm), FATIGUE (A lot of tiredness), PYREXIA (Fever) and CHILLS (Chills) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No concomitant medication details were not reported by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN (Body ache), PAIN IN EXTREMITY (Sore arm), FATIGUE (A lot of tiredness), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, PAIN (Body ache), PAIN IN EXTREMITY (Sore arm), FATIGUE (A lot of tiredness), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details were not reported by the reporter.
Pt. c/o needle phobia before shot was given. C/O dizziness, itchiness and pain when shot was given. Went to walk-in clinic 1 day after shot c/o generalized itching - slight relief with BENADRYL. Pain - slight relief with Ibuprofen. Main relief with ice.
Hospitalized 10/12/2021; COVID-19 positive 10/12/2021; fully vaccinated 65 y.o. male who presents today with complaints of shortness of breath progressively worsening over the past 10 days. He was seen by his PCP and treated for COPD exacerbation but states that his symptoms continued to worsen. He endorses exposure to COVID 19 in both his son and daughter. He does report being vaccinated in 3/2021. He also complains of nonproductive cough. Initially, in the ED his oxygen sats were 70s on his home oxygen requirements of 2 L n/c requiring 6L n/c to improve oxygen sats greater than 90%. Patient denies fever/chills. He does endorse diarrhea yesterday morning. In the ED he was COVID 19 positive and procalcitonin was 0.35 indicating that a bacterial infection is likely. He was started on IV antibiotics and dexamethasone per the ED provider. His sodium level was low and IVF were given.  ASSESSMENT/PLAN: * COVID-19 pneumonia Assessment & Plan - symptom onset 10 days - positive test 10/12/2021 - vaccinated for COVID 19 3/2021 - procalcitonin 0.35 (likely bacterial infection); start rocephin and azithromycin - son & daughter +COVID - wears home oxygen at 2L n/c; required 6L n/c on presentation - out of window for remdesivir - dexamethasone 10mg daily - check ddimer - Pulmonary toiletry IS - Tessalon perles - Lovenox VTE prophylaxis Note from 10/14/2021: CHIEF COMPLAINT: COVID-19 virus infection follow up     Assessment/Plan    ASSESSMENT / PLAN: * COVID-19 pneumonia Assessment & Plan - symptom onset 10 days - positive test 10/12/2021 - vaccinated for COVID 19 3/2021 - procalcitonin 0.35 (likely bacterial infection); continue rocephin and azithromycin day #3 - son & daughter +COVID - wears home oxygen at 3L n/c; required 6L n/c on presentation - out of window for remdesivir - will change to solumedrol from dexamethasone in the setting of COPD exacerbation - Pulmonary toiletry IS - Tessalon perles - Lovenox VTE prophylaxis
Pt c/o of pain when moving arm up and down where vaccine was given. No redness no swelling no induration noted.
brief period of feeling extreme heaviness in shoulders and arms, tingling hands/feet. Followed by muscle aches, general body tension, chills, mild headache. Also ear/jaw pain (possibly related to prior sinus infection)
Fever 102 for more than 24 hours, slight cough, heaviness in chest
Within 2 minutes post vax, the pt developed a lump in her throat, chest rash, and severe headache. She received a shot of cortisone and prescribed Percocet in the ER. She felt better. On 2/22/99, her symptoms started again and she developed blurred vision. On 3/1/99, she was seen by her allergist who administered Decadron and Demerol. On 3/10/99, her whole body swelled and she developed severe chest pains, headaches, and tremors. She stopped taking all of her medications on her own behalf. She developed painful pressure in her arms and legs and could hardly walk. On 3/17/99, she developed swelling in her legs and retained 7 lbs of water. Her headaches worsened. On 3/27/99, the swelling improved. She was seen by her chiropractor because she was experiencing a loss of endurance in her arms and developed nerve pain in her legs. On 2/20/99, she developed headache, chest pain described as chest burning, shortness of breath, and throat closing. She was treated in the ER with Dacadron, Demerol, Valium, and Tagamet. She complained of tinnitus at night.
Pain at site (bad). Collapsed; did not know people or year; was taken to ER. Admitted to hospital on Thurs.; released on Sat. 10-13-18. Blood tests; X-rays (chest); EKG; Brain scan; were performed.
Infant started with bleeding from nose lasted 1 hr also had minor fall sustained large ecchymosis and multiple unexplained other bruises to body (ITP). 01/08/07-records received and reviewed. DOS 12/8-12/9/06 DX: ITP. PMH: acute viral GE approximately 2 weeks ago.  Bruising present on head, arms, legs, trunk  Treated with IVIG.  Admitted subsequently 12/14-12/15/06- DC DX: acute gastroenteritis. History of vomiting and diarrhea. Temp 102.8. Treated with IVF
brief lightheadedness  Pt arrived at observation area at 1500. Was informed she has a history of allergies in teh past so instructed patient to wait or 30 minutes in observation area. Around 1505, pt stated she was feeling lightheaded, near syncope. Advised pt to lay on ground. Vitals taken - BP 140s/90s, with HR 118, pulse ox 100%. After 5 min, pt stated she was feeling better while laying down. At 1515, vitals retaken with BP 120s/80s HR 90s. At 1520, pt sat up from floor still feeling better. At 1525 pt sat in chair feeling better and at 1530 pt stated feeling no side effects.
Patient experienced chest pain and flushing. EKG was done. Pt felt better. Had subsequent ECHO and HOLTER and work up by cardiology.
Headache, body ache, low grade fever, fatigue , leg pains / cramps the whole night
pt recvd vax & 6hrs p/vax exp paresthesias w/progression to include entire body;also had episode of subjective weakness w/o objective findings;exp shivers,weakness,& joint pains;seen by MD;suspects that may have MS;
Site: Pain at Injection Site-Mild, Systemic: Fainting / Unresponsive-Severe
Varicella virus vaccine was ordered due to a non immune varicella titer result. the pharmacy dispensed a Zostavax vial in a ziplock bag that was labeled with the patients name and  Varicella Vaccine use for Varivax.  The LPN who administered the vaccine did not realize that zostavax(shingles vaccine)  is not a substitute for varivax. The error was discovered when the nurse asked for assistance in charting the vaccine and was advised by another LPN that this might be the incorrect vaccine. The vial and the bag was brought to me as the clinic manager. Since we do not stock either Zostavax or Varivax the only way we would have it is if the pharmacy dispensed it for this particular patient. The order to the pharmacy did request the Varivax not Zostrix.  We do not administer the zostrix to our patients at this time since we provide occupationally related care.  To date there has been no adverse response, no local reaction, Merck was contacted and they  sent a letter advising that the patient be given varivax  in one month as the 2nd dose of a 2 dose series for varicella protection
pt reported perfect white circles or splotches on right arm after injection around injection site up her arm to her neck, chest, and around her back and down to her elbow they did not itch were not red or raised
Developed lightheaded episode on 10/26 then irregular heart rhythm noted and PVC's diagnosed with home cardio mobile machine, contacted doctor and was seen on 10/27/2021
Influenza vaccination administration to an unintended patient (patient did not request influenza vaccination). She only requested Shingrix administration, but both were given.
Patient had symptoms of headache, fever, cough and rhinorrhea on 20May2022 and positive antigen test that afternoon; Patient had symptoms of headache, fever, cough and rhinorrhea on 20May2022 and positive antigen test that afternoon; This is a spontaneous report received from a non-contactable reporter(s) (Nurse).  A 62-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 28Jan2021 as dose 1, single (Lot number: EL3247), in left arm, on 18Feb2021 as dose 2, single (Lot number: EL3247), in left arm and on 09Nov2021 as dose 3 (booster), single (Lot number: FF2589) at the age of 61 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 20May2022, outcome "unknown" and all described as "Patient had symptoms of headache, fever, cough and rhinorrhea on 20May2022 and positive antigen test that afternoon". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (20May2022) Positive, notes: Nasal Swab. It was unknown if therapeutic measures were taken as a result of vaccination failure, covid-19.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the known safety profile and Limited information in the case report a casual association between LOE events and suspect drug BNT162B2 cannot be excluded.
had a delayed reaction of small tight blisters or sores that look like little chicken pox or measles all over her body; They are very small little blisters that are very itchy and look like they have a blister on top; This is a spontaneous report from a contactable consumer or other non-Health Care Professional. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry date: Unknown), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for Covid-19 immunization.The patient medical history was not reported. The patient's concomitant medications were not reported.On an unspecified date the patient experienced had a delayed reaction of small tight blisters or sores that look like little chicken pox or measles all over her body , they are very small little blisters that are very itchy and look like they have a blister on top. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. ; Sender's Comments: Yiour
pt recv vax 7OCT96 & same day exp rash;pt rash persisted @ the time of the report;f/u pt dx w/impetigo;
Administered pediatric Pfizer Covid 19 vaccine dose.  No adverse outcomes/ symptoms presented by patient.
I'm sick as heck; Initial information received on 28-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves Adult and unknown gender patient who reported  i'm sick as heck after receiving Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant disease or risk factor and family history were not provided.   On an unknown date, the patient received a  dose of suspect Influenza Vaccine by unknown manufacturer (strength, formulation, dose, route, batch number and expiry date: unknown) via unknown route in unknown administration site for Influenza.  On an unknown date the patient reported i'm sick as heck (illness) (unknown latency).  It was reported that "Didn't help me. I'm sick as heck".  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (I'm sick as heck).  At time of reporting, the outcome was Unknown for the event i'm sick as heck.
11/02/2021 & 11/03/2021- I was in bed for 36 hours with  headache, fatigue,  malaise, joint pain,  chills. 11/12/2021-started with a little bit of rashes, on breast area for the 1 st day. 11/13/2021 just a little bit of rash.  The 11/14 , 11/15 and today 11/16/2021 is rash is full body and out of  control.   My co-worker received the 3rd dose of Moderna the day after, 11/02/2021,  I received my  3rd dose of  vaccine and 10 days post vaccine she is now covered in a full body rash also.  I had a consultation with my doctor over the phone. He is aware of the rash. I have been trying since yesterday to get an appointment with my doctor to see if he could prescribe me Prednisone.  11/16/2021- I have not recovered from the rash. It is getting worse day by day.
Dizziness, light-headed, mild chest tightness, no difficulty breathing, VSS-WNL  2 doses Benadryl, followed by epinephrine.  She refused to go to hospital or MD.
pt recv vax later next day became sick (malaise, fatigue) did not come to work;
injection site is round; hard; warm to touch; itchy; injection site reaction lastin more than a week; sweet taste in mouth; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (sweet taste in mouth), VACCINATION SITE SWELLING (injection site is round), VACCINATION SITE INDURATION (hard), VACCINATION SITE WARMTH (warm to touch) and VACCINATION SITE PRURITUS (itchy) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced DYSGEUSIA (sweet taste in mouth). On an unknown date, the patient experienced VACCINATION SITE SWELLING (injection site is round), VACCINATION SITE INDURATION (hard), VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itchy) and INJECTION SITE REACTION (injection site reaction lastin more than a week). On 12-Jan-2021, DYSGEUSIA (sweet taste in mouth) had resolved. At the time of the report, VACCINATION SITE SWELLING (injection site is round), VACCINATION SITE INDURATION (hard), VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itchy) and INJECTION SITE REACTION (injection site reaction lastin more than a week) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
Swollen Lymph Node in left armpit(golf ball size) Swollen lymph node in neck on left side (pea size). Pain and itchiness at injection site
Patient was sitting down when EMS noticed patient stand up from chair and fell face forward. Patient had LOC for approximately 20secs. Manual c-spine was applied. EMS notes facial trauma where 2-3 teeth where missing. Viral signs obtained on scene. Med tech transferred care to rescue-6 without change in patient condition.
possible increase in seizure activity since getting the second Covid vaccine. reports having fatigue and memory loss (short term and difficulty recalling details) after having 2nd vaccine. Hx of nocturnal seizures.  Employee reports saw Neurologist (2/12/12)- reports advised that employee should be off work all next week. States having EEG and blood work done. States symptoms slightly. As noted after second Covid shot on 2/2, he had "41 events" on CPAP that night then had low grade fevers, chills, and headache for a few days which resolved but had continued fatigue, incoordination, and memory loss, forgot "things I knew before the vaccine". improving.
Right side of face started to swell with blotching. It then went away .  Injection site is raised , swelling and itching along with bruising .  Hives began again on my arms and injection site .
Information has been received from a physician concerning a 2-month-old patient who was vaccinated with a dose of Rotateq. The physician reported that the patient threw up not long after being vaccinated. Unspecified medical attention was sought. At the time of this report, the outcome was unknown. No further information is available.
Redness, swelling, pain at the injection site. Dizziness lasting more than a week. Treated redness and pain with Ibuprofen 400 mg one to twice a day PRN. Outcome: no longer having any of these symptoms. Left arm appears normal, no redness and/or swelling at the injection site and no dizziness.
recovering from COVID; recovering from COVID; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 90-year-old male patient received BNT162b2 (BNT162B2), on 08Feb2021 as dose 1, 0.3 ml single (Batch/Lot number: unknown) and on 04Mar2021 as dose 2, 0.3 ml single (Batch/Lot number: unknown) at the age of 88 years for covid-19 immunisation. The patient's relevant medical history included: "CKD 4/5" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), outcome "unknown", COVID-19 (medically significant), outcome "recovering" and all described as "recovering from COVID".  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on available information, a possible contributory role of the subject product , BNT162B2 vaccine, cannot be excluded for suspected LOE.  There is limited information provided in this report. This case will be reassessed upon receipt of follow-up information.,Linked Report(s) : US-PFIZER INC-202300199917 same patient and suspect drug/different AE;US-PFIZER INC-PV202300091944 sam epatient/different suspect drug and AE;
Initial and follow up information has been received from a licensed practical nurse and an unspecified member of the physician's office concerning a 9 week old white female with no known allergies who was born at 36 weeks and had a history of developing a rash to cedar. On 4/5/04, the patient was vaccinated IM with the first dose of 0.5ml pneumococcal 23v polysaccharide vaccine (lot 649979/0531P). Concomitant suspect therapy previously reported included diphtheria toxoid (+) hepatitis B virus vaccine (+) pertussis acellular 3-component vaccine (+) poliovirus vaccine inactivated (+) tetanus toxoid and HIB conjugate vaccine. At the time of vaccination, it was reported that the patient had a slight cold. On 4/6/05 the patient was noted to have a temperature of 99.6 F. At that time it was reported that the patient was a little cranky and had a slight congestion that was no worse than yesterday. It was reported that the patient sought unspecified medical attention. The reporter assessed that initially the patient did not have any change in her history and physical, however, several days later, she was admitted to the hospital, much for which we have no follow up. It was reported that the patient had not returned to the physician's office for follow up. At the time of this report, the outcome of the events were unknown (previously reported that the patient had not recovered from the pyrexia, irritability, and nasal congestion). No further information is available.
Caused me fatigue; This is a spontaneous report from a Pfizer sponsored program received from a contactable female consumer (patient). A female patient of an unspecified age received second dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, on 29May2021 (Batch/Lot number and Expiry date was not reported) as single dose, for Covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number and Expiry date was not reported) as single dose for covid-19 immunisation and got two menstrual cycles. On an unspecified date in 2021, the patient experienced fatigue. Outcome of the event fatigue was unknown.  Information about lot/batch number has been requested.